Hempfusion Wellness Inc
TSX:CBD.U

Watchlist Manager
Hempfusion Wellness Inc Logo
Hempfusion Wellness Inc
TSX:CBD.U
Watchlist
Price: 0.035 USD Market Closed
Market Cap: 4.1m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

CBD.U doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of CBD.U.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CBD.U Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

0.7
P/S
P/S
Price to Sales
0.7
vs History
vs Industry
Median 3Y
0.7
Median 5Y
0.7
Industry
1.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-0.1
Industry
17.6
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.2
Industry
12
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.2
Industry
16.9
More Details
0.2
P/B
P/B
Price to Book Value
0.2
vs History
vs Industry
Median 3Y
0.2
Median 5Y
0.2
Industry
1.6
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-0.1
Industry
1.2
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
3.9
More Details
0
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
0
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
More Details
0
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
0
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
13.1
More Details
0
EV/OCF
EV/OCF
Enterprise Value to OCF
0
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
12.6
More Details
0
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
0
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
15.2
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0
Industry
1.2
More Details

Multiples Across Competitors

CBD.U Competitors Multiples
Hempfusion Wellness Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Hempfusion Wellness Inc
TSX:CBD.U
4.1m USD 0.7 -0.1 0 0
FR
L'Oreal SA
PAR:OR
193.7B EUR 4.5 30.2 18.6 22.6
UK
Unilever PLC
LSE:ULVR
110B GBP 2.1 22.1 145.9 168.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.8T INR 9.3 54.9 38.6 42.5
UK
HALEON PLC
LSE:HLN
32.5B GBP 2.9 22.5 13.5 15.3
US
Estee Lauder Companies Inc
NYSE:EL
31.4B USD 2.1 -36 16.6 27
DE
Beiersdorf AG
XETRA:BEI
24B EUR 2.4 26.3 11 13.4
JP
Kao Corp
TSE:4452
3.1T JPY 1.9 27.2 12.4 19.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 8.9 69.1 41.6 45.1
IN
Dabur India Ltd
NSE:DABUR
926.2B INR 7.4 52.4 39.1 48.4
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 855.7 -4 624.4 -6 373.4 -6 360.4
P/E Multiple
Earnings Growth PEG
US
Hempfusion Wellness Inc
TSX:CBD.U
Average P/E: 38.1
Negative Multiple: -0.1 		N/A N/A
FR
L'Oreal SA
PAR:OR
30.2
9%
3.4
UK
Unilever PLC
LSE:ULVR
22.1
14%
1.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
54.9
8%
6.9
UK
HALEON PLC
LSE:HLN
22.5
13%
1.7
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -36
40%
N/A
DE
Beiersdorf AG
XETRA:BEI
26.3
12%
2.2
JP
Kao Corp
TSE:4452
27.2
10%
2.7
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
69.1
21%
3.3
IN
Dabur India Ltd
NSE:DABUR
52.4
13%
4
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Hempfusion Wellness Inc
TSX:CBD.U
Average EV/EBITDA: 33.7
0
N/A N/A
FR
L'Oreal SA
PAR:OR
18.6
6%
3.1
UK
Unilever PLC
LSE:ULVR
145.9
3%
48.6
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
38.6
8%
4.8
UK
HALEON PLC
LSE:HLN
13.5
5%
2.7
US
Estee Lauder Companies Inc
NYSE:EL
16.6
3%
5.5
DE
Beiersdorf AG
XETRA:BEI
11
2%
5.5
JP
Kao Corp
TSE:4452
12.4
7%
1.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
41.6
14%
3
IN
Dabur India Ltd
NSE:DABUR
39.1
12%
3.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 373.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Hempfusion Wellness Inc
TSX:CBD.U
Average EV/EBIT: 40.3
0
N/A N/A
FR
L'Oreal SA
PAR:OR
22.6
6%
3.8
UK
Unilever PLC
LSE:ULVR
168.8
3%
56.3
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
42.5
9%
4.7
UK
HALEON PLC
LSE:HLN
15.3
5%
3.1
US
Estee Lauder Companies Inc
NYSE:EL
27
4%
6.7
DE
Beiersdorf AG
XETRA:BEI
13.4
2%
6.7
JP
Kao Corp
TSE:4452
19.4
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
45.1
15%
3
IN
Dabur India Ltd
NSE:DABUR
48.4
14%
3.5
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 360.4 N/A N/A

See Also

Summary
CBD.U intrinsic value, competitors valuation, and company profile.
DCF Valuation
CBD.U stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CBD.U stock valuation using valuation multiples.
Wall Street Estimates
CBD.U price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CBD.U stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 269,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.